Thomas Leggett, Chief Financial Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 3,000 shares at $33.94 ($102K) on 2021-01-08, disclosed to the SEC on 2021-01-11.
Open-market sale of $102k BDTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BDTX | SELL | 2020-11-12 | $99K | — | Filing → |
| BDTX | SELL | 2020-10-09 | $101K | — | Filing → |
| BDTX | SELL | 2020-09-16 | $93K | — | Filing → |